Svelte Medical Systems, Inc. Announces Start of the FAASTER Post-Market Registry Study

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Svelte® Medical Systems today announced the start of the FAASTER (First Assessment of the Acrobat Stenting Technique European Post-Market Registry) study in clinical sites across Europe. FAASTER is a real world, multi-center registry assessing the procedural success and resource utilization associated with the Svelte coronary stent mounted on an Integrated Delivery System (IDS) in relation to target lesion and vessel complexity (as defined by NAVI-score) and selected catheter approach (diagnostic or guiding). Up to 1,500 patients will be evaluated in the study.